Literature DB >> 7522690

Inhibition of stem cell factor dependent formation of human mast cells by interleukin-3 and interleukin-4.

C Sillaber1, W R Sperr, H Agis, E Spanblöchl, K Lechner, P Valent.   

Abstract

In murines, interleukins (IL) 3, 4, 9, and 10, nerve growth factor, and stem cell factor induce or promote growth and differentiation of mast cells (MC). Increased stimulation and synergy was observed when combinations of cytokines were used. In man, no growth factor for human MCs had been identified until recently, when SCF was found to induce in vitro growth and differentiation of human MCs. In the present study, the effects of recombinant human IL-3 and IL-4 on SCF-dependent differentiation of human MCs from their circulating progenitor cells in long-term culture were analyzed. Surprisingly, both IL-3 and IL-4 were found to inhibit SCF-dependent formation of human MCs (SCF, 100 ng/ml: 36.4 +/- 18.7 x 10(3)/ml; SCF + IL-3, 100 U/ml: 23.4 +/- 4.2 x 10(3)/ml; SCF + IL-4, 100 U/ml: 7.4 +/- 4.4 x 10(3)/ml) and synthesis of MC tryptase (SCF, 100 ng/ml: 73.2 +/- 17.6 ng/ml; SCF + IL-3, 100 U/ml: 10.8 +/- 3.1 ng/ml [p < 0.01]; SCF + IL-4, 100 U/ml: 8.1 +/- 1.5 ng/ml, [p = 0.02]). The inhibitory effects of these cytokines on SCF-dependent formation of human MCs were associated with an increase in the number of macrophages (IL-3) or lymphocytes (IL-4) in the same cultures and may be due to competitive recruitment of cells from a pool of multilineage hematopoietic progenitor cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7522690     DOI: 10.1159/000236767

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  9 in total

Review 1.  Molecular regulation of mast cell development and maturation.

Authors:  Chenxiong Liu; Zhigang Liu; Zhilong Li; Yaojiong Wu
Journal:  Mol Biol Rep       Date:  2009-07-31       Impact factor: 2.316

2.  IL-4 enhances proliferation and mediator release in mature human mast cells.

Authors:  S C Bischoff; G Sellge; A Lorentz; W Sebald; R Raab; M P Manns
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

Review 3.  Development, migration, and survival of mast cells.

Authors:  Yoshimichi Okayama; Toshiaki Kawakami
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 4.  Signal transduction-associated and cell activation-linked antigens expressed in human mast cells.

Authors:  Peter Valent; Minoo Ghannadan; Alexander W Hauswirth; Gerit-Holger Schernthaner; Wolfgang R Sperr; Michel Arock
Journal:  Int J Hematol       Date:  2002-05       Impact factor: 2.490

5.  KIT signaling is dispensable for human mast cell progenitor development.

Authors:  Joakim S Dahlin; Maria Ekoff; Jennine Grootens; Liza Löf; Rose-Marie Amini; Hans Hagberg; Johanna S Ungerstedt; Ulla Olsson-Strömberg; Gunnar Nilsson
Journal:  Blood       Date:  2017-08-08       Impact factor: 22.113

6.  T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro.

Authors:  H Ochi; W M Hirani; Q Yuan; D S Friend; K F Austen; J A Boyce
Journal:  J Exp Med       Date:  1999-07-19       Impact factor: 14.307

Review 7.  Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond.

Authors:  Bettina Sprinzl; Georg Greiner; Goekhan Uyanik; Michel Arock; Torsten Haferlach; Wolfgang R Sperr; Peter Valent; Gregor Hoermann
Journal:  Int J Mol Sci       Date:  2021-02-28       Impact factor: 5.923

8.  Interferon-γ regulates growth and controls Fcγ receptor expression and activation in human intestinal mast cells.

Authors:  Gernot Sellge; Miriam Barkowsky; Sigrid Kramer; Thomas Gebhardt; Leif E Sander; Axel Lorentz; Stephan C Bischoff
Journal:  BMC Immunol       Date:  2014-07-05       Impact factor: 3.615

Review 9.  Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts.

Authors:  Peter Valent; Cem Akin; Karin Hartmann; Gunnar Nilsson; Andreas Reiter; Olivier Hermine; Karl Sotlar; Wolfgang R Sperr; Luis Escribano; Tracy I George; Hanneke C Kluin-Nelemans; Celalettin Ustun; Massimo Triggiani; Knut Brockow; Jason Gotlib; Alberto Orfao; Petri T Kovanen; Emir Hadzijusufovic; Irina Sadovnik; Hans-Peter Horny; Michel Arock; Lawrence B Schwartz; K Frank Austen; Dean D Metcalfe; Stephen J Galli
Journal:  Theranostics       Date:  2020-08-29       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.